CDMO News
Icosagen Partners with LDC to Boost GPCR-Targeted Treatments
Icosagen, a Contract Research and Development Manufacturing Organisation (CRDMO) based in Estonia, has announced a strategic partnership with the Lead Discovery Center GmbH (LDC), a translational drug discovery organisation. The collaboration, announced on 15 May 2024, is focused on the
16 May 2024